Name
NeoLife International Osaühing
Registry code
10003057
VAT number
EE100257559
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
24.11.1995 (28)
Financial year
01.01-31.12
Capital
7 030.00 €
Activity
46391 - Non-specialised wholesale of food, beverages and tobacco
3 129 478 €
196 030 €
6%
-
576 799 €
10
Submitted
No tax arrears
34%
20%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Margus Mugu 23.12.1966 (57) | - | Procurator | - | |
| Rok Podlesnik 06.06.1979 (45) | - | Board member | - |
| 2019 02.03.2020 | 2020 11.05.2021 | 2021 10.05.2022 | 2022 05.04.2023 | 2023 14.05.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 2 174 377 € | 2 771 526 € | 3 422 348 € | 2 961 382 € | 3 129 478 € |
| Net profit (loss) for the period | 113 723 € | 238 546 € | 182 854 € | 162 116 € | 196 030 € |
| Profit Margin | 5% | 9% | 5% | 5% | 6% |
| Current Assets | 782 971 € | 970 681 € | 828 349 € | 817 018 € | 954 289 € |
| Fixed Assets | 8 988 € | 8 560 € | 5 547 € | 7 587 € | 11 624 € |
| Total Assets | 791 959 € | 979 241 € | 833 896 € | 824 605 € | 965 913 € |
| Current Liabilities | 414 707 € | 363 443 € | 285 244 € | 293 836 € | 389 114 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 377 252 € | 615 798 € | 548 652 € | 530 769 € | 576 799 € |
| Employees | 8 | 8 | 9 | 9 | 10 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 1 268 739.19 € | 126 823.54 € | 58 148.66 € | 12 |
| 2023 Q4 | 1 497 168.28 € | 166 460.18 € | 53 004.24 € | 12 |
| 2023 Q3 | 1 448 124.55 € | 133 452.35 € | 42 828.19 € | 12 |
| 2023 Q2 | 1 259 975.85 € | 107 342.81 € | 41 243.09 € | 10 |
| 2023 Q1 | 1 538 103.62 € | 202 315.99 € | 37 694.62 € | 10 |
| 2022 Q4 | 1 304 670.52 € | 139 181.27 € | 35 144.76 € | 9 |
| 2022 Q3 | 1 552 624.69 € | 151 260.37 € | 35 153.34 € | 10 |
| 2022 Q2 | 1 515 746.63 € | 174 807.02 € | 31 170.15 € | 9 |
| 2022 Q1 | 1 768 097.9 € | 177 452.99 € | 33 186.37 € | 9 |
| 2021 Q4 | 1 463 334.85 € | 127 548.61 € | 31 833.06 € | 9 |
| 2021 Q3 | 1 708 119.95 € | 153 256.48 € | 30 640.93 € | 9 |
| 2021 Q2 | 2 403 728.95 € | 211 761.42 € | 29 537.81 € | 9 |
| 2021 Q1 | 1 387 227.27 € | 101 669.52 € | 33 285.39 € | 9 |
| 2020 Q4 | 1 294 509.84 € | 71 055.96 € | 26 833.59 € | 8 |
| 2020 Q3 | 1 277 189.51 € | 72 200.43 € | 26 966.94 € | 8 |
| 2020 Q2 | 1 213 028.61 € | 71 901.92 € | 26 430.66 € | 8 |
| 2020 Q1 | 967 840.22 € | 69 898.01 € | 26 646.61 € | 8 |
